Skip to main content
. 2020 Sep 16;10:575316. doi: 10.3389/fonc.2020.575316

Table 2.

Comparison of baseline clinicopathological characteristics based on PBD status.

Variables No PBD PBD P
Total number 184 242
Sex (%)
 Male 121 (65.8) 166 (68.6) 0.607
 Female 63 (34.2) 76 (31.4)
Age (%), years
  ≤ 65 109 (59.2) 133 (55.0) 0.433
 >65 75 (40.8) 109 (45.0)
TB before intervention (%), μmol/L
  ≤ 150 89 (48.4) 30 (12.4) <0.001
 >150 95 (51.6) 212 (87.6)
Albumin before intervention (%), g/L
  <35 68 (37.0) 132 (54.5) <0.001
 ≥35 116 (63.0) 110 (45.5)
Elapsed time from PBD to surgery (%), weeks
  <4 NA 202 (83.5)
 ≥4 NA 40 (16.5)
TB before surgery (%), μmol/L
  ≤ 150 89 (48.4) 158 (65.3) 0.001
 >150 95 (51.6) 84 (34.7)
Albumin before surgery (%), g/L
  <35 67 (36.4) 93 (38.4) 0.745
 ≥35 117 (63.6) 149 (61.6)
NLR (%)
  ≤ 2 31 (16.8) 40 (16.5) 1.000
 >2 153 (83.2) 202 (83.5)
Surgery method (%)
 OPD 160 (87.0) 202 (83.5) 0.390
 MIPD 24 (13.0) 40 (16.5)
Venous resection (%)
 No 164 (89.1) 212 (87.6) 0.739
 Yes 20 (10.9) 30 (12.4)
T stage (%)
 T1–3 159 (88.3) 204 (86.8) 0.642
 T4 21 (11.7) 31 (13.2)
N stage (%)
 N0 92 (51.1) 111 (47.2) 0.434
 N1/N2 88 (48.9) 124 (52.8)
Differentiation (%)
 Good 60 (33.7) 63 (27.0) 0.143
 Moderate–Poor 118 (66.3) 170 (73.0)
Resection margins (%)
 Negative 142 (77.2) 190 (78.5) 0.832
 Positive (R1/R2) 42 (22.8) 52 (21.5)
Post-operative complication (%)
 No 108 (58.7) 130 (53.7) 0.354
 Yes 76 (41.3) 112 (46.3)
Adjuvant chemotherapy (%)
 No 79 (42.9) 119 (49.2) 0.238
 Yes 105 (57.1) 123 (50.8)

MIPD, minimally invasive pancreaticoduodenectomy; NLR, neutrophil-lymphocyte ratio; OPD, open pancreaticoduodenectomy; PBD, pre-operative biliary drainage; TB, total serum bilirubin.